Citadel Advisors’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,777
| Closed | -$22.6K | – | 7422 |
|
|
2025
Q1 | $22.6K | Buy |
+42,777
| New | +$22.6K | ﹤0.01% | 5564 |
|
|
2024
Q3 | – | Sell |
-8,912
| Closed | -$144K | – | 6940 |
|
|
2024
Q2 | $144K | Hold |
8,912
| – | – | ﹤0.01% | 4794 |
|
|
2024
Q1 | $902K | Sell |
8,912
-956
| -10% | -$96.7K | ﹤0.01% | 3298 |
|
|
2023
Q4 | $233K | Buy |
9,868
+1,427
| +17% | +$33.7K | ﹤0.01% | 4457 |
|
|
2023
Q3 | $174K | Sell |
8,441
-24,585
| -74% | -$506K | ﹤0.01% | 4621 |
|
|
2023
Q2 | $859K | Buy |
33,026
+1,830
| +6% | +$47.6K | ﹤0.01% | 3133 |
|
|
2023
Q1 | $649K | Hold |
31,196
| – | – | ﹤0.01% | 3618 |
|
|
2022
Q4 | $636K | Sell |
31,196
-82
| -0.3% | -$1.67K | ﹤0.01% | 3639 |
|
|
2022
Q3 | $863K | Buy |
31,278
+82
| +0.3% | +$2.26K | ﹤0.01% | 3558 |
|
|
2022
Q2 | $824K | Sell |
31,196
-23
| -0.1% | -$608 | ﹤0.01% | 3618 |
|
|
2022
Q1 | $2.5M | Sell |
31,219
-18
| -0.1% | -$1.44K | ﹤0.01% | 2777 |
|
|
2021
Q4 | $6.37M | Sell |
31,237
-72
| -0.2% | -$14.7K | ﹤0.01% | 1884 |
|
|
2021
Q3 | $10.1M | Sell |
31,309
-498
| -2% | -$161K | ﹤0.01% | 1428 |
|
|
2021
Q2 | $8.26M | Buy |
31,807
+10,296
| +48% | +$2.67M | ﹤0.01% | 1617 |
|
|
2021
Q1 | $8.3M | Buy |
+21,511
| New | +$8.3M | ﹤0.01% | 1585 |
|